The PCR London Valves issue of EuroIntervention opens with a state-of-the-art on TAVI in biscuspid aortic stenosis; followed by an expert consensus commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC on transcatheter tricuspid valve interventions in patients with transvalvular right ventricular leads; a Viewpoint on the ACURATE platform discontinuation; original research on coronary cannulation after transfemoral TAVI with the Evolut FX; HALT after TAVI with the SAPIEN Ultra RESILIA; the impact of aortic annular size on long-term outcomes and valve durability; the TRICURE first-in-human study; 5-year follow-up of EVOQUE TTVR; and more...